Hence, we propose that SOX2OT alleviates cell proliferation and fibrosis in DN by regulating Akt/mTOR-mediated autophagy, indicating that SOX2OT may represent a novel target for DN treatment. Here, AKT1 is linked to liver dysplastic nodule.